UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records diagnoses. Shares dropped about 9% in midday trading, weighing on the Dow industrials.

UnitedHealth Group (UNH) on Friday refuted claims by The Wall Street Journal that the US Department of Justice had launched an investigation into the health insurer's Medicare billing practices. The Journal reported Friday,

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the shortage of Novo Nordisk's Ozempic and Wegovy has ended.

Key Takeaways Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply.The company makes compounded versions of weight-loss drugs under an FDA rule that applies when the originals are difficult to obtain.